Reynders McVeigh Capital Management, LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 289 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
Reynders McVeigh Capital Management, LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$547,000
-42.7%
12,174
-27.9%
0.04%
-44.6%
Q4 2020$955,000
+25.0%
16,895
+4.9%
0.06%
+10.2%
Q3 2020$764,000
-22.1%
16,110
-3.2%
0.06%
-31.4%
Q2 2020$981,000
+12.9%
16,640
-9.5%
0.09%
-13.1%
Q1 2020$869,000
-30.1%
18,390
-10.7%
0.10%
-17.5%
Q4 2019$1,244,000
+0.8%
20,5900.0%0.12%
-9.1%
Q3 2019$1,234,000
-13.2%
20,590
-6.9%
0.13%
-13.2%
Q2 2019$1,421,000
-20.3%
22,110
+0.7%
0.15%
-22.8%
Q1 2019$1,782,000
+77.7%
21,960
+18.3%
0.20%
+48.1%
Q4 2018$1,003,000
+141.1%
18,560
+130.3%
0.13%
+171.4%
Q3 2018$416,000
-23.8%
8,060
-38.4%
0.05%
-30.0%
Q2 2018$546,000
-9.8%
13,095
-4.6%
0.07%
-9.1%
Q1 2018$605,000
-13.7%
13,720
-1.6%
0.08%
-16.3%
Q4 2017$701,000
-3.8%
13,945
-3.0%
0.09%
-3.2%
Q3 2017$729,000
-10.4%
14,370
-10.2%
0.10%
-12.8%
Q2 2017$814,000
+18.1%
15,995
-6.7%
0.11%
+14.7%
Q1 2017$689,000
-32.8%
17,145
-20.0%
0.10%
-34.9%
Q4 2016$1,025,000
-13.0%
21,420
-33.4%
0.15%
-15.1%
Q3 2016$1,178,000
-12.7%
32,160
-44.5%
0.17%
-12.2%
Q2 2016$1,350,000
-70.4%
57,983
-48.6%
0.20%
-71.0%
Q1 2016$4,568,000
-34.4%
112,797
+0.2%
0.68%
-40.8%
Q4 2015$6,968,000112,5221.14%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,046$126,5576.89%
M28 Capital Management LP 126,300$4,513,9625.10%
Bellevue Group AG 9,511,900$339,955,3064.93%
Deep Track Capital, LP 2,834,069$101,289,6264.16%
BVF INC/IL 2,560,761$91,521,5983.35%
Sicart Associates LLC 210,698$7,530,3472.93%
Privium Fund Management B.V. 182,773$6,532,3072.19%
Camber Capital Management LP 1,925,000$68,8002.12%
Orbimed Advisors 2,124,500$75,929,6301.49%
SECTOR GAMMA AS 146,441$5,233,8011.27%
View complete list of IONIS PHARMACEUTICALS INC shareholders